SECTOR ANALYSIS

Rare Oncology Biotech Companies

Grades, scores, and FDA catalyst signals for Rare Oncology stocks tracked by BiotechSigns

← Full ScreenerFDA CalendarAll Sectors
Companies
19
Avg Score
58
Top Grade
B
Rare Oncology Companies19 tracked
TickerCompanyScoreGradeSectorSignals
BOLTBolt Biotherapeutics79BOncology
NUVBNuvation Bio70BOncology
HOOKHOOKIPA Pharma67BOncology
LBPHLongboard Pharmaceuticals66BOncology
HCMHUTCHMED China65BOncology
DCPHDeciphera Pharmaceuticals64COncology
KPTIKaryopharm Therapeutics64COncology
KURAKura Oncology, Inc.63COncology
CELCCelcuity Inc59COncology
TOIThe Oncology Institute, Inc.59COncology
INCYIncyte Corporation56COncology
KRONKronos Bio53COncology
CRVSCorvus Pharmaceuticals53COncology
BMYBristol-Myers Squibb52COncology
ALXOALX Oncology51COncology
SNDXSyndax Pharmaceuticals49DOncology
TGTXTG Therapeutics48DOncology
BCABBioAtla Inc47DOncology
BGNEBeiGene Ltd44DOncology
Not financial advice. All data and analysis provided by Guerilla Finance Inc. BiotechSigns grades and scores are algorithmic signals only and do not constitute investment recommendations. Biotech investing involves significant risk, including the potential for complete loss of capital on binary FDA events. Always conduct your own due diligence before making investment decisions.